Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Anemia

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 18 articles:
HTML format



Single Articles


    October 2021
  1. DONATO AA, Green J
    In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk.
    Ann Intern Med. 2021;174:JC110.
    PubMed     Abstract available


    September 2021
  2. KANTER J
    One Small Step for Sickle Cell Disease: Many More to Go.
    Ann Intern Med. 2021;174:1313-1314.
    PubMed    


    July 2021
  3. CLIFT AK, Saatci D, Coupland CAC, Dambha-Miller H, et al
    Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1375.
    PubMed    


  4. JIANG D, Garcia D
    In patients with AMI and anemia, a restrictive vs. liberal blood transfusion strategy was noninferior for 30-d MACE.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed     Abstract available



  5. Summary for Patients: Treating Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/P21-0005.
    PubMed    


  6. LANZKRON S, Little J, Wang H, Field JJ, et al
    Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/M20-7171.
    PubMed     Abstract available


  7. LACOMBE V, Kosmider O, Prevost M, Lavigne C, et al
    Severe Joint Involvement in VEXAS Syndrome: A Case Report.
    Ann Intern Med. 2021;174:1025-1027.
    PubMed    


  8. DESAI P, Little J, Kanter J, Bridges K, et al
    Kneeling Was the First Step for Sickle Cell Disease.
    Ann Intern Med. 2021;174:1004-1005.
    PubMed    


    April 2021
  9. DEFILIPPIS EM, Van Spall HGC
    In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y.
    Ann Intern Med. 2021;174:JC45.
    PubMed     Abstract available


    January 2021
  10. PECKER LH, Lanzkron S
    Sickle Cell Disease.
    Ann Intern Med. 2021;174:ITC1-ITC16.
    PubMed     Abstract available


    December 2020
  11. FAUGHNAN ME, Mager JJ, Hetts SW, Palda VA, et al
    Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
    Ann Intern Med. 2020;173:989-1001.
    PubMed     Abstract available


    November 2020
  12. SCHIAVON CA, Bhatt DL, Ikeoka D, Santucci EV, et al
    Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension : A Randomized Clinical Trial.
    Ann Intern Med. 2020;173:685-693.
    PubMed     Abstract available


    July 2020
  13. CENTOR RM, Vallurupalli M
    Web Exclusive. Annals On Call - Why Do Patients Develop Anemia With Chronic Inflammation?
    Ann Intern Med. 2020;173:OC1.
    PubMed    



  14. Correction: Effects of Interleukin-1beta Inhibition on Incident Anemia.
    Ann Intern Med. 2020 Jul 14. doi: 10.7326/L20-0934.
    PubMed    


    April 2020
  15. LOCALIO AR, Meibohm AR, Guallar E
    Finding the Pathway: Mediation Analyses in Randomized Controlled Trials.
    Ann Intern Med. 2020;172:553-557.
    PubMed    


    March 2020
  16. VALLURUPALLI M, MacFadyen JG, Glynn RJ, Thuren T, et al
    Effects of Interleukin-1beta Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial.
    Ann Intern Med. 2020 Mar 24. pii: 2763494. doi: 10.7326/M19-2945.
    PubMed     Abstract available


    February 2020
  17. SOARES C, Gilson M
    Nifedipine-Induced Shock in Pregnancy With Aortic Stenosis.
    Ann Intern Med. 2020;172:221-222.
    PubMed    


    August 2019
  18. SAMSKY MD, Newby LK
    Review: In HF with iron deficiency, iron supplementation reduces HF admissions and improves cardiac function.
    Ann Intern Med. 2019;171:JC19.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: